摘要
在最近的几十年中,人们对整合素受体在癌症生物学特别是在前列腺肿瘤的发展中的应用越来越感兴趣。有报道称整合素能调控多种机制,如细胞的存活、增殖、分化和迁移。本文报道了整合素信号机制在转移性前列腺肿瘤发展、肿瘤生长原发灶和转移灶之间的信号联系、肿瘤细胞和组织微环境之间的相互作用和上皮间质转化(EMT)中的作用。最后,本文讨论了以整合素为基础的化疗药物在临床上的作用,并对以整合素为靶点作为癌症药物提出了深刻的见解。
关键词: 拮抗剂治疗,整合素,前列腺癌。
Current Drug Targets
Title:Therapeutic Value of an Integrin Antagonist in Prostate Cancer
Volume: 17 Issue: 3
Author(s): Clement-Lacroix Philippe
Affiliation:
关键词: 拮抗剂治疗,整合素,前列腺癌。
摘要: In recent decades we have seen an exponential interest in the implications of integrin receptors in cancer biology and especially in prostate tumour development. Integrins has been reported to control multiple mechanisms, such as cell survival, proliferation, differentiation, and migration. Here, we report the current understanding of the integrin signalling mechanisms in metastatic prostate tumour development, cross-talks between the primary and metastatic sites on tumour growth, interactions between tumour cells and tissue microenvironment, and epithelial-mesenchymal transition (EMT). Finally, this review presents the integrin-based chemotherapeutic agents currently under clinically consideration and provides an insight into cancer drug development using integrin as a target.
Export Options
About this article
Cite this article as:
Clement-Lacroix Philippe , Therapeutic Value of an Integrin Antagonist in Prostate Cancer, Current Drug Targets 2016; 17 (3) . https://dx.doi.org/10.2174/1389450117666151209115324
DOI https://dx.doi.org/10.2174/1389450117666151209115324 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy
Current Cancer Drug Targets Porphyrins in Photodynamic Therapy - A Search for Ideal Photosensitizers
Current Medicinal Chemistry - Anti-Cancer Agents Recent Applications of Nanomaterials Based on Electrochemical Drug Analysis
Current Analytical Chemistry Nanoliposomal Encapsulation Enhances In Vivo Anti-Tumor Activity of Niclosamide against Melanoma
Anti-Cancer Agents in Medicinal Chemistry Meet the Editorial Board:
Recent Patents on Anti-Cancer Drug Discovery The Endocrine System and Sarcopenia: Potential Therapeutic Benefits
Current Aging Science Aging and DNA Methylation
Current Chemical Biology Effects of Tea Polyphenols and their Polymers on MAPK Signaling Pathways in Cancer Research
Mini-Reviews in Medicinal Chemistry The IGF Axis in Prostate Cancer
Current Pharmaceutical Design Effect of PI3K/AKT/mTOR Signaling Pathway on Regulating and Controlling the Anti-Invasion and Metastasis of Hepatoma Cells by Bufalin
Recent Patents on Anti-Cancer Drug Discovery Role of TGF-β in Melanoma
Current Pharmaceutical Biotechnology Polyphenols and Aging
Current Aging Science Curcumin and its Multi-target Function Against Pain and Inflammation: An Update of Pre-clinical Data
Current Drug Targets Review of the Biological Activity of Maslinic Acid
Current Drug Targets Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Current Drug Targets Stem Cell-Mediated Gene Delivering for the Treatment of Cerebral Ischemia: Progress and Prospectives
Current Drug Targets Natural Polyphenols and their Synthetic Analogs as Emerging Anticancer Agents
Current Drug Targets Overcoming the Hurdles of Tumor Immunity by Targeting Regulatory Pathways in Innate and Adaptive Immune Cells
Current Pharmaceutical Design Integrated, Molecular Engineering Approaches to Develop Prostate Cancer Gene Therapy
Current Gene Therapy Sauropus androgynus Leaves for Health Benefits: Hype and the Science
The Natural Products Journal